The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management

Liquid biopsy (LB) has boosted a remarkable change in the management of cancer patients by contributing to tumour genomic profiling. Plasma circulating cell-free tumour DNA (ctDNA) is the most widely searched tumour-related element for clinical application. Specifically, for patients with lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Maria Gabriela O., Cruz-Martins, Natália, Machado, José Carlos, Costa, José Luís, Hespanhol, Venceslau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680243/
https://www.ncbi.nlm.nih.gov/pubmed/34915883
http://dx.doi.org/10.1186/s12935-021-02382-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680243/
https://www.ncbi.nlm.nih.gov/pubmed/34915883
http://dx.doi.org/10.1186/s12935-021-02382-0

Ejemplares similares